title: Survey of neuropeptide gene expression in tumor cell lines.
abstract: The presence of 3 different neuropeptide mRNAs with a strict cell-specific expression in vivo was investigated in 13 tumor cell lines from neuroendocrine and in 23 tumor cell lines from non-neuroendocrine origin. Northern blots showed no expression of mRNA for vasopressin (VP) in the 36 tested cell lines. Very low oxytocin (OT) mRNA hybridization signals were detected in the rat pituitary tumor cell line GH4C2 and the rat pancreas tumor cell line RIN5. Both the rat pituitary tumor cell line AtT-20 and the human myeloid leukemia cell line K562, contained proopiomelanocortin (POMC) mRNA. The low incidence of VP, OT and POMC gene expression in the tested tumor cell lines was not influenced by treatments inducing differentiation. In contrast, the cholecystokinin (CCK) gene which is widely present in nervous and endocrine systems was abundantly expressed in the human primitive neuroepithelioma cell line SK-N-MC and its clonal derivative SK-N-MC-IX-C. The results indicate that the expression of neuropeptide genes is very rare in tumor cell lines. The lack of expression in undifferentiated cells agrees with the appearance of expression after day 13 of the embryogenesis when maturation of neurons begins.
authors.affiliation: Rudolf Magnus Institute, Medical Faculty, University of Utrecht, The Netherlands.
authors.forename: M A
authors.initials: MA
authors.lastname: Verbeeck
authors.forename: C L
authors.initials: CL
authors.lastname: Mummery
authors.forename: A
authors.initials: A
authors.lastname: Feijen
authors.forename: J P
authors.initials: JP
authors.lastname: Burbach
mesh_terms: D000818:Animals; D015152:Blotting, Northern; D002454:Cell Differentiation / Q000187:drug effects; D002766:Cholecystokinin / Q000096:biosynthesis / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D009374:Neoplasms, Experimental / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D009380:Neoplasms, Nerve Tissue / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D009479:Neuropeptides / Q000096:biosynthesis* / Q000235:genetics; D010121:Oxytocin / Q000096:biosynthesis / Q000235:genetics; D009384:Paraneoplastic Endocrine Syndromes / Q000235:genetics*; D011333:Pro-Opiomelanocortin / Q000096:biosynthesis / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis; D012334:RNA, Neoplasm / Q000032:analysis; D051381:Rats; D013552:Swine; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism*; D014667:Vasopressins / Q000096:biosynthesis / Q000235:genetics
chemical_list: D009479:Neuropeptides; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D014667:Vasopressins; D010121:Oxytocin; D011333:Pro-Opiomelanocortin; D002766:Cholecystokinin